Browsing by Author "Goel, P K"
Now showing 1 - 16 of 16
Results Per Page
Sort Options
Item Authors’ response(2016-06) Nair, V; Madan, H; Sofat, S; Ganguli, P; Jacob, M J; Datta, R; Bharadwaj, P; Sarkar, R S; Pandit, A J; Nityanand, S; Goel, P K; Garg, N; Gambhir, S; George, P V; Chandy, S; Mathews, V; George, O K; Talwar, K K; Bahl, A; Marwah, N; Bhatacharya, A; Bhargava, B; Airan, B; Mohanty, S; Patel, C D; Sharma, A; Bhatnagar, S; Mondal, A; Jose, J; Srivastava, AItem Calcified mobile papillary fibroelastoma of the tricuspid valve: a case report.(1987-05-01) Mohan, J C; Goel, P K; Gambhir, D S; Khanna, S K; Arora, RItem Changing trends in permanent cardiac pacing--sixteen years experience.(1987-05-01) Yadav, B S; Gadkari, M; Babu, M R; Chaudhary, A; Goel, P K; Sethi, K K; Gambhir, D S; Lochan, R; Bahl, V K; Kaul, U AItem "Concertina" effect during angioplasty of tortuous right and left coronary arteries and importance of using over-the-wire system: a case report.(2001-01-18) Goel, P K; Agarwal, A; Kapoor, AA case wherein "Concertina" effect appeared during angioplasty of both right and left coronary arteries is described. Also, the advantages of using an over-the-wire system in such cases are stressed especially when extreme tortuosity and total occlusion are present together.Item Double right coronary artery with anomalous left main and septal arteries originating from the right coronary sinus.(2002-07-05) Garg, Naveen; Goel, P K; Sinha, NakulAnomalies of the coronary artery are often asymptomatic and are uncommon in the general population. We present a case of a double right coronary artery along with anomalous origin of the left main coronary artery and first septal perforator, all originating from the right coronary sinus.Item Efficacy of a new transdermal nitroglycerin system in the treatment of stable angina pectoris.(1987-11-01) Gambhir, D S; Goel, P K; Arora, R; Khalilullah, MItem Electrophysiological effects of intravenous amiodarone in patients with intraventricular conduction disorders.(1988-07-01) Gambhir, D S; Goel, P K; Sriram, S; Arora, R; Khalilullah, MItem Massive congenital submitral aneurysm of the left ventricle: a case report.(1989-09-01) Mohan, J C; Goel, P K; Khanna, S K; Arora, RSubannular left ventricular aneurysm adjacent to the mitral valve is a rare entity predominantly seen in the young blacks. A young Indian patient with massive submitral left ventricular aneurysm (10.6 cm x 7.5 cm) presenting with congestive heart failure is reported with 2D-echocardiographic, haemodynamic and cineangiographic and pathologic data.Item Mitral balloon valvotomy: a new therapeutic modality for the non-surgical management of mitral stenosis.(1985-05-01) Khalilullah, M; Bahl, V K; Choudhary, A; Yadav, B S; Babu, M R; Goel, P K; Natarajan, D; Manoharan, S; Kaul, U A; Arora, RItem Multifocal cardiac myxoma: report of a rare clinical entity.(2002-11-04) Goel, P K; Anand, K V; Srivastava, A K; Pal, LilyPrimary tumors of the heart and pericardium are rare, with myxomas representing the majority. Myxomas, if multiple, are mostly biatrial in location. We report a case with four tumors in three chambers of the heart, including both ventricles, which were identified by transthoracic echocardiography and successfully operated.Item Persistent left superior vena cava drainage into left atrium with tetralogy of Fallot: a case report.(1987-07-01) Mohan, J C; Goel, P K; Sethi, K K; Arora, RItem 'Ping-Pong' inside the heart.(2000-09-21) Garg, N; Kapoor, A; Kanhare, V; Goel, P KItem Premature coronary artery disease in North India: an angiography study of 1971 patients.(2005-07-15) Tewari, Satyendra; Kumar, Sudeep; Kapoor, Aditya; Singh, Uttam; Agarwal, Ajay; Bharti, B B; Garg, Naveen; Goel, P K; Sinha, NakulBACKGROUND: South Asians, specially Indians, show increased risk for atherosclerosis and have the highest mortality rates due to coronary artery disease amongst all ethnic groups studied so far. We aimed to find out the differences in clinical-biochemical and angiographic profile of young patients versus older patients with angiographically proven atherosclerotic coronary artery disease. METHODS AND RESULTS: Group I (n=828) consisted of patients with age above 55 years (mean age: 63.15 +/- 5.76 years), group II (n=924, mean age: 49.13 +/- 4.25 years) consisted of patients between age 41-55 years and group III (n=219) consisted of patients with age < or = 40 years (mean age: 37.37 +/- 2.92 years). Among the conventional risk factors, smoking was significantly more frequent in group III, while diabetes mellitus and systemic hypertension were more prevalent in groups II and I. Q wave myocardial infarction was more frequently present in groups II and III. Only about one-third of the entire patient population in the myocardial infarction group received thrombolytic therapy. Total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels were significantly higher in younger patients (groups II and III), while high-density lipoprotein cholesterol was significantly low in whole cohort but more so in older patients. Single vessel involvement was more common in group III, while multi-vessel involvement, diffuse disease and fluoroscopic calcium were more common in groups I and II. CONCLUSIONS: Significant differences were observed in the clinical, biochemical and angiographic profile of young patients with coronary artery disease as compared to elderly patients. The younger cohort had more atherogenic lipid profile, higher prevalence of smoking and more frequent single vessel disease. We observed that total cholesterol/high-density lipoprotein cholesterol ratio was a better predictor of coronary artery disease as compared to individual lipid levels.Item A relook at the reporting of coronary angiograms in the interventional era: a perspective.(1997-05-01) Goel, P KItem Right atrial myxoma--a report of two cases.(1985-03-01) Kaul, U A; Goel, P K; Tyagi, S; Bahl, V K; Mahorkar, U; Khanna, S K; Khalilullah, MItem Role of thrombolytic therapy for stuck prosthetic valves: a serial echocardiographic study.(2001-07-05) Kumar, S; Garg, N; Tewari, S; Kapoor, A; Goel, P K; Sinha, NBACKGROUND: Thrombotic occlusion of a prosthetic valve continues to be an uncommon but serious complication. Intravenous thrombolytic therapy has been proposed as an alternative to surgical treatment, but only in critically ill patients. METHODS AND RESULTS: Forty-one consecutive patients presenting with 48 episodes of prosthetic valve thrombosis (44 mitral and 4 aortic) were treated with thrombolytic therapy under serial echocardiographic guidance. There were 14 male and 27 female patients. The anticoagulation status was inadequate in 89.6% of episodes. Atrial fibrillation was present in 47.9% of episodes. The prostheses involved in these episodes were tilting disc in 45, bileaflet in 2, and ball and cage type in 1. The Sorin prosthetic valve was the most commonly involved. The time interval between valve replacement and thrombosis ranged from 1 month to 108 months (mean 20.4+/-20.6 months). Patients were in New York Heart Association functional class III in 47.9% and in class II in 43.9% of episodes. Thrombolytic agents used were streptokinase and urokinase in 44 and 4 episodes, respectively. The mean duration of thrombolytic therapy was 27.9+/-15.0 hours and the overall success rate was 87.5%. Patients developed peripheral embolism with almost complete recovery in 5 episodes while significant bleeding that required termination of thrombolytic therapy was observed in 2 episodes. Redo valve replacement was done in 3 episodes because these patients did not improve on thrombolytic therapy (all 3 cases were of recurrent prosthetic valve thrombosis and were found to have pannus peroperatively). Three patients died during thrombolytic therapy because of persistent heart failure. Six patients experienced a total of 13 epidoses of recurrent prosthetic valve thrombosis including index episodes (rethrombosis in 5, re-rethrombosis in 1). They were treated with repeated thrombolysis with a success rate of 76.92%. The mean duration of thrombolytic therapy in these episodes was 36.1+/-14.0 hours. CONCLUSIONS: In patients with prosthetic valve thrombosis, intravenous thrombolysis guided by echocardiography is a safe and effective method that may expand the indications for nonsurgical treatment of prosthetic valve thrombosis. By using serial echocardiography, the duration of thrombolytic therapy can be tailored to the patient's requirement for normalization of valve hemodynamics.